CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99 | +70.7% | 3,615 | +112.5% | 0.00% | – |
| Q2 2023 | $58 | -4.9% | 1,701 | 0.0% | 0.00% | – |
| Q1 2023 | $61 | -34.4% | 1,701 | -17.8% | 0.00% | – |
| Q4 2022 | $93 | -99.8% | 2,070 | 0.0% | 0.00% | – |
| Q3 2022 | $58,000 | +3.6% | 2,070 | 0.0% | 0.00% | – |
| Q2 2022 | $56,000 | -25.3% | 2,070 | 0.0% | 0.00% | – |
| Q1 2022 | $75,000 | -6.2% | 2,070 | 0.0% | 0.00% | – |
| Q4 2021 | $80,000 | -29.2% | 2,070 | 0.0% | 0.00% | – |
| Q3 2021 | $113,000 | +32.9% | 2,070 | -18.8% | 0.00% | – |
| Q2 2021 | $85,000 | +63.5% | 2,550 | 0.0% | 0.00% | – |
| Q1 2021 | $52,000 | +15.6% | 2,550 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | – | 2,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |